Free Trial

Anteris Technologies Global (AVR) Competitors

Anteris Technologies Global logo
$3.25 -0.03 (-0.91%)
As of 04:00 PM Eastern

AVR vs. DCTH, TMCI, SNWV, CATX, CLPT, OM, RXST, NNOX, NPCE, and NYXH

Should you be buying Anteris Technologies Global stock or one of its competitors? The main competitors of Anteris Technologies Global include Delcath Systems (DCTH), Treace Medical Concepts (TMCI), Sanuwave Health (SNWV), Perspective Therapeutics (CATX), ClearPoint Neuro (CLPT), Outset Medical (OM), RxSight (RXST), Nano-X Imaging (NNOX), NeuroPace (NPCE), and Nyxoah (NYXH). These companies are all part of the "medical equipment" industry.

Anteris Technologies Global vs. Its Competitors

Anteris Technologies Global (NASDAQ:AVR) and Delcath Systems (NASDAQ:DCTH) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, profitability, media sentiment, earnings, risk, dividends, valuation and analyst recommendations.

Delcath Systems has higher revenue and earnings than Anteris Technologies Global.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Anteris Technologies Global$2.70M43.41-$76.29MN/AN/A
Delcath Systems$37.21M10.68-$26.39M-$0.50-22.82

Anteris Technologies Global currently has a consensus price target of $16.50, indicating a potential upside of 407.69%. Delcath Systems has a consensus price target of $24.00, indicating a potential upside of 110.34%. Given Anteris Technologies Global's higher possible upside, equities research analysts plainly believe Anteris Technologies Global is more favorable than Delcath Systems.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Anteris Technologies Global
0 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
3.00
Delcath Systems
0 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
3.00

Anteris Technologies Global has a net margin of 0.00% compared to Delcath Systems' net margin of -26.38%. Anteris Technologies Global's return on equity of 0.00% beat Delcath Systems' return on equity.

Company Net Margins Return on Equity Return on Assets
Anteris Technologies GlobalN/A N/A N/A
Delcath Systems -26.38%-29.44%-20.75%

In the previous week, Delcath Systems had 3 more articles in the media than Anteris Technologies Global. MarketBeat recorded 4 mentions for Delcath Systems and 1 mentions for Anteris Technologies Global. Anteris Technologies Global's average media sentiment score of 1.87 beat Delcath Systems' score of 1.14 indicating that Anteris Technologies Global is being referred to more favorably in the media.

Company Overall Sentiment
Anteris Technologies Global Very Positive
Delcath Systems Positive

61.1% of Delcath Systems shares are owned by institutional investors. 17.4% of Delcath Systems shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Summary

Anteris Technologies Global beats Delcath Systems on 6 of the 11 factors compared between the two stocks.

Get Anteris Technologies Global News Delivered to You Automatically

Sign up to receive the latest news and ratings for AVR and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AVR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AVR vs. The Competition

MetricAnteris Technologies GlobalMED INSTRUMENTS IndustryMedical SectorNASDAQ Exchange
Market Cap$118.28M$6.85B$5.70B$9.51B
Dividend YieldN/A1.27%4.69%4.01%
P/E RatioN/A25.4528.0720.05
Price / Sales43.4163.57448.5799.42
Price / CashN/A20.5536.2258.56
Price / Book1.874.758.665.87
Net Income-$76.29M$176.14M$3.25B$258.55M
7 Day Performance6.56%2.92%4.20%2.23%
1 Month Performance-17.93%3.56%10.82%12.76%
1 Year PerformanceN/A7.66%34.70%19.36%

Anteris Technologies Global Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AVR
Anteris Technologies Global
N/A$3.25
-0.9%
$16.50
+407.7%
N/A$118.28M$2.70M0.00138
DCTH
Delcath Systems
2.7562 of 5 stars
$11.42
+0.9%
$24.00
+110.2%
+29.0%$397.76M$37.21M-22.8460News Coverage
TMCI
Treace Medical Concepts
2.8538 of 5 stars
$5.75
-0.7%
$10.52
+82.9%
-26.6%$361.30M$209.36M-6.76250Positive News
SNWV
Sanuwave Health
N/A$38.54
+3.0%
N/AN/A$330.29M$32.63M-8.4640
CATX
Perspective Therapeutics
2.3736 of 5 stars
$4.22
+2.2%
$12.56
+197.5%
-67.5%$313.24MN/A0.0070News Coverage
CLPT
ClearPoint Neuro
2.1277 of 5 stars
$11.12
-2.3%
$25.00
+124.9%
+48.0%$311.25M$31.39M-14.63110News Coverage
OM
Outset Medical
1.5534 of 5 stars
$17.50
-0.6%
$29.50
+68.6%
-69.4%$309.83M$113.69M-0.60520Positive News
RXST
RxSight
2.4548 of 5 stars
$7.37
-0.2%
$17.50
+137.6%
-83.4%$298.91M$139.93M-10.98220Trending News
NNOX
Nano-X Imaging
1.9295 of 5 stars
$5.17
+1.9%
$9.50
+83.9%
-35.0%$298.43M$11.28M-5.74190News Coverage
Positive News
NPCE
NeuroPace
3.4538 of 5 stars
$9.08
-0.1%
$17.00
+87.3%
+12.4%$297.50M$79.91M-10.80170Positive News
NYXH
Nyxoah
2.5015 of 5 stars
$8.20
-0.9%
$14.50
+76.7%
-4.8%$279.43M$4.89M-3.85110

Related Companies and Tools


This page (NASDAQ:AVR) was last updated on 7/25/2025 by MarketBeat.com Staff
From Our Partners